Form 4: Hims & Hers Health CFO Oluyemi Okupe Reports Stock Transactions

Chief Financial Officer Oluyemi Okupe of Hims & Hers Health, Inc. reports the vesting and disposal of restricted stock units to cover tax obligations.

Summary

• On March 14, 2025, Oluyemi Okupe, the CFO of Hims & Hers Health, Inc., reported transactions involving Class A Common Stock and Restricted Stock Units (RSUs).
• Okupe acquired 93,718 shares of Class A Common Stock through the vesting of RSUs.
• 51,671 shares were disposed of to cover tax withholding obligations at a price of $33.14 per share.
• Following these transactions, Okupe directly owns 152,366 shares of Class A Common Stock.
• The transactions also involved the vesting of 52,395, 18,335, and 22,988 RSUs, leaving Okupe with 209,581, 146,675, and 275,857 RSUs respectively.
• The RSUs vest over a 4-year period, with varying commencement dates for the quarterly installments.

Sentiment

Score: 5

Explanation: This is a neutral report on stock transactions, with no inherent positive or negative sentiment. It's a routine disclosure.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading activities.
• Similar filings are made by executives at companies like Teladoc Health and GoodRx, which operate in related telehealth and pharmaceutical sectors.
• The vesting schedules and tax withholding practices are typical for RSU grants in the tech and healthcare industries.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation and tax obligations.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates